Regulacje i polityka gospodarcza · 08/12/2005

Expression Pathology, Inc. to Receive Exclusive Patent License for Laser Microdissection Technology

The US Department of the Navy has announced its intention to grant Expression Pathology, Inc. a non-exclusive, revocable license to use its government-owned inventions related to laser microdissection technology for life science research, therapeutics, and clinical diagnostics in the US and certain foreign countries.